Discharge Planning in Emergency Department for Frail Older With AHF

NCT ID: NCT03696875

Last Updated: 2019-07-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

1260 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-05-20

Study Completion Date

2022-05-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Objectives: To demonstrate the efficacy of care transition holistic intervention (Multilevel Guided Discharge Planning, MGDP) in reducing 30-day adverse outcomes among frail older patients with acute heart failure (AHF) discharged from Emergency Departments (EDs) and to validate the results of MGDP in real life.

Method: Investigators will select frail patients ≥70 years with primary diagnosis of AHF discharged from EDs. The intervention will consist of MGDP implementation: 1) checklist that includes clinical recommendations and resources activations; 2) scheduling of early visit with the specialist; 3) communication with primary care; 4) providing a written instruction sheet to patient or caregiver. Phase 1: matched-pair cluster randomized clinical trial. EDs were randomly allocated to intervention (n = 10) or control (n = 10) group. Investigators will compare the outcomes between intervention and control groups. Phase 2: a quasi-experimental study. The 20 EDs will carry out the intervention. Investigators will compare the outcomes between phase 1 and phase 2 of intervention group and between phase 1 and phase 2 of control group. The main outcome is a 30-day composite endpoint (ED revisit or hospital admission for AHF and cardiovascular death) after being discharged.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Heart Failure Frail Elderly Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Phase 1: Matched-pair cluster randomized clinical trial. Phase 2: a quasi-experimental study.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Multilevel Guided Discharge Planning

Group Type EXPERIMENTAL

Multilevel Guided Discharge Planning

Intervention Type OTHER

Clinical recommendations and resources activations + scheduling of early visit with the specialist + communication with primary care + written instruction sheet to the patient

Standard of care

Group Type ACTIVE_COMPARATOR

Standard of care

Intervention Type OTHER

Standard of care

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Multilevel Guided Discharge Planning

Clinical recommendations and resources activations + scheduling of early visit with the specialist + communication with primary care + written instruction sheet to the patient

Intervention Type OTHER

Standard of care

Standard of care

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥70 years.
* Diagnosis of descompensated chronic heart failure.
* Screening for frailty positive (ISAR ≥ 2).
* Planned discharge home from Emergency Department (included observation and short stay unit).
* Written informed consent provided by the patient or proxy.

Exclusion Criteria

* De novo (new onset) acute heart failure (AHF).
* Severe episode of acute heart failure (≥9th decile of MEESSI-AHF Score).
* Uncorrected clinically significant primary valvular disease.
* Acute coronary syndrome currently or within 30 days prior to enrolment.
* Surgery or implanted device within 30 days prior to enrolment.
* Significant arrhythmias.
* Uncorrected systolic blood pressure \< 100 mmHg, O2 saturation baseline \< 92%, heart rate \< 60 or \>110 bpm, serum sodium \< 130 mmol/l, serum potassium \>5,5 mmol/l or hemoglobin \<9 g/dL prior to enrolment.
* Planned treatment with vasoactive therapies, ventricular assist device, heart surgery or transplant within 6 months.
* End stage renal disease.
* Severe disability.
* Difficulty intervention due to significant dementia, active delirium or psychiatric disorder.
* Condition with a life expectancy \<1 year.
* Length of stay in Emergency Department ≥96 hours.
* Discharged to facility care.
* Inability of outpatient follow-up.
Minimum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

F. Javier Martin Sanchez

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

F. Javier Martin Sanchez

Principal Investigator

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Clinico San Carlos

Madrid, , Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Francisco Javier Martín-Sánchez, MD, PhD.

Role: CONTACT

+34 91.330.37.50

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Martin Sanchez, MD

Role: primary

913303750

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DEED FRAIL-AHF

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.